Human Insulin Market
Human Insulin Market - Global Industry Assessment & Forecast
#
Pages:
205
Base Year:
2022
Dec - 2024
Format:
Report Code:
VMR-1911
Segments Covered
By
Product Drugs, Delivery Devices
-
By
Product Type Insulin Analoys & Biosimilars, Human Insulin Biologics
-
By
Diabetes Type Diabetes 1, Diabetes 2
-
By
Delivery Devices Pens, Pen Needles, Syringes
-
By
Region North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Snapshot
 Base Year:
|
2022 |
| Forecast
Years:
|
2023 - 2030 |
 Historical
Years:
|
2017 - 2021 |
 Revenue
2022: |
USD 22.66 Billion |
 Revenue 2030:
|
USD 28.71 Billion |
 Revenue CAGR
(2023 - 2030): |
3.00% |
Fastest Growing Region (2023 -
2030)
|
Asia Pacific |
Largest Region (2022):
|
North America |
Customization Offered
Cross-segment Market Size and
Analysis
for Mentioned Segments- Additional Company Profiles (Upto 5
With
No Cost)
- Additional Countries (Apart From
Mentioned Countries)
- Country/Region-specific Report
- Go To Market Strategy
- Region Specific Market Dynamics
- Region Level Market Share
- Import Export Analysis
- Production Analysis
- Others Request
Customization Speak To
Analyst
Human Insulin Market Segment Analysis
- Human Insulin Product Outlook (Revenue, USD Million, 2018 - 2030)
- Drugs
- Delivery Devices
- Human Insulin Product Type Outlook (Revenue, USD Million, 2018 - 2030)
- Insulin Analoys & Biosimilars
- Human Insulin Biologics
- Human Insulin Diabetes Type Outlook (Revenue, USD Million, 2018 - 2030)
- Diabetes 1
- Diabetes 2
- Human Insulin Delivery Devices Outlook (Revenue, USD Million, 2018 - 2030)
- Pens
- Pen Needles
- Syringes
-
Regional Outlook (Revenue, USD Billion/Million, 2018 - 2030)
- North America
-
North America Human Insulin Market, by Product
- Drugs
- Delivery Devices
-
North America Human Insulin Market, by Product Type
- Insulin Analoys & Biosimilars
- Human Insulin Biologics
-
North America Human Insulin Market, by Diabetes Type
- Diabetes 1
- Diabetes 2
-
North America Human Insulin Market, by Delivery Devices
- Pens
- Pen Needles
- Syringes
- U.S.
- U.S. Human Insulin Market, by Product
- Drugs
- Delivery Devices
- U.S. Human Insulin Market, by Product Type
- Insulin Analoys & Biosimilars
- Human Insulin Biologics
- U.S. Human Insulin Market, by Diabetes Type
- Diabetes 1
- Diabetes 2
- U.S. Human Insulin Market, by Delivery Devices
- Pens
- Pen Needles
- Syringes
- U.S. Human Insulin Market, by Product
- Canada
- Canada Human Insulin Market, by Product
- Drugs
- Delivery Devices
- Canada Human Insulin Market, by Product Type
- Insulin Analoys & Biosimilars
- Human Insulin Biologics
- Canada Human Insulin Market, by Diabetes Type
- Diabetes 1
- Diabetes 2
- Canada Human Insulin Market, by Delivery Devices
- Pens
- Pen Needles
- Syringes
- Canada Human Insulin Market, by Product
-
Mexico
- Mexico Human Insulin Market, by Product
- Drugs
- Delivery Devices
- Mexico Human Insulin Market, by Product Type
- Insulin Analoys & Biosimilars
- Human Insulin Biologics
- Mexico Human Insulin Market, by Diabetes Type
- Diabetes 1
- Diabetes 2
- Mexico Human Insulin Market, by Delivery Devices
- Pens
- Pen Needles
- Syringes
- Mexico Human Insulin Market, by Product
-
North America Human Insulin Market, by Product
- Europe
-
Europe Human Insulin Market, by Product
- Drugs
- Delivery Devices
-
Europe Human Insulin Market, by Product Type
- Insulin Analoys & Biosimilars
- Human Insulin Biologics
-
Europe Human Insulin Market, by Diabetes Type
- Diabetes 1
- Diabetes 2
-
Europe Human Insulin Market, by Delivery Devices
- Pens
- Pen Needles
- Syringes
- U. K.
- U.K. Human Insulin Market, by Product
- Drugs
- Delivery Devices
- U.K. Human Insulin Market, by Product Type
- Insulin Analoys & Biosimilars
- Human Insulin Biologics
- U.K. Human Insulin Market, by Diabetes Type
- Diabetes 1
- Diabetes 2
- U.K. Human Insulin Market, by Delivery Devices
- Pens
- Pen Needles
- Syringes
- U.K. Human Insulin Market, by Product
- France
- France Human Insulin Market, by Product
- Drugs
- Delivery Devices
- France Human Insulin Market, by Product Type
- Insulin Analoys & Biosimilars
- Human Insulin Biologics
- France Human Insulin Market, by Diabetes Type
- Diabetes 1
- Diabetes 2
- France Human Insulin Market, by Delivery Devices
- Pens
- Pen Needles
- Syringes
- France Human Insulin Market, by Product
-
Germany
- Germany Human Insulin Market, by Product
- Drugs
- Delivery Devices
- Germany Human Insulin Market, by Product Type
- Insulin Analoys & Biosimilars
- Human Insulin Biologics
- Germany Human Insulin Market, by Diabetes Type
- Diabetes 1
- Diabetes 2
- Germany Human Insulin Market, by Delivery Devices
- Pens
- Pen Needles
- Syringes
- Germany Human Insulin Market, by Product
-
Italy
- Italy Human Insulin Market, by Product
- Drugs
- Delivery Devices
- Italy Human Insulin Market, by Product Type
- Insulin Analoys & Biosimilars
- Human Insulin Biologics
- Italy Human Insulin Market, by Diabetes Type
- Diabetes 1
- Diabetes 2
- Italy Human Insulin Market, by Delivery Devices
- Pens
- Pen Needles
- Syringes
- Italy Human Insulin Market, by Product
-
Spain
- Spain Human Insulin Market, by Product
- Drugs
- Delivery Devices
- Spain Human Insulin Market, by Product Type
- Insulin Analoys & Biosimilars
- Human Insulin Biologics
- Spain Human Insulin Market, by Diabetes Type
- Diabetes 1
- Diabetes 2
- Spain Human Insulin Market, by Delivery Devices
- Pens
- Pen Needles
- Syringes
- Spain Human Insulin Market, by Product
-
Rest of Europe
- Rest of Europe Human Insulin Market, by Product
- Drugs
- Delivery Devices
- Rest of Europe Human Insulin Market, by Product Type
- Insulin Analoys & Biosimilars
- Human Insulin Biologics
- Rest of Europe Human Insulin Market, by Diabetes Type
- Diabetes 1
- Diabetes 2
- Rest of Europe Human Insulin Market, by Delivery Devices
- Pens
- Pen Needles
- Syringes
- Rest of Europe Human Insulin Market, by Product
-
Europe Human Insulin Market, by Product
- Asia Pacific
-
Asia Pacific Human Insulin Market, by Product
- Drugs
- Delivery Devices
-
Asia Pacific Human Insulin Market, by Product Type
- Insulin Analoys & Biosimilars
- Human Insulin Biologics
-
Asia Pacific Human Insulin Market, by Diabetes Type
- Diabetes 1
- Diabetes 2
-
Asia Pacific Human Insulin Market, by Delivery Devices
- Pens
- Pen Needles
- Syringes
- China
- China Human Insulin Market, by Product
- Drugs
- Delivery Devices
- China Human Insulin Market, by Product Type
- Insulin Analoys & Biosimilars
- Human Insulin Biologics
- China Human Insulin Market, by Diabetes Type
- Diabetes 1
- Diabetes 2
- China Human Insulin Market, by Delivery Devices
- Pens
- Pen Needles
- Syringes
- China Human Insulin Market, by Product
- Japan
- Japan Human Insulin Market, by Product
- Drugs
- Delivery Devices
- Japan Human Insulin Market, by Product Type
- Insulin Analoys & Biosimilars
- Human Insulin Biologics
- Japan Human Insulin Market, by Diabetes Type
- Diabetes 1
- Diabetes 2
- Japan Human Insulin Market, by Delivery Devices
- Pens
- Pen Needles
- Syringes
- Japan Human Insulin Market, by Product
-
Germany
- Germany Human Insulin Market, by Product
- Drugs
- Delivery Devices
- Germany Human Insulin Market, by Product Type
- Insulin Analoys & Biosimilars
- Human Insulin Biologics
- Germany Human Insulin Market, by Diabetes Type
- Diabetes 1
- Diabetes 2
- Germany Human Insulin Market, by Delivery Devices
- Pens
- Pen Needles
- Syringes
- Germany Human Insulin Market, by Product
-
India
- India Human Insulin Market, by Product
- Drugs
- Delivery Devices
- India Human Insulin Market, by Product Type
- Insulin Analoys & Biosimilars
- Human Insulin Biologics
- India Human Insulin Market, by Diabetes Type
- Diabetes 1
- Diabetes 2
- India Human Insulin Market, by Delivery Devices
- Pens
- Pen Needles
- Syringes
- India Human Insulin Market, by Product
-
South Korea
- South Korea Human Insulin Market, by Product
- Drugs
- Delivery Devices
- South Korea Human Insulin Market, by Product Type
- Insulin Analoys & Biosimilars
- Human Insulin Biologics
- South Korea Human Insulin Market, by Diabetes Type
- Diabetes 1
- Diabetes 2
- South Korea Human Insulin Market, by Delivery Devices
- Pens
- Pen Needles
- Syringes
- South Korea Human Insulin Market, by Product
-
South East Asia
- South East Asia Human Insulin Market, by Product
- Drugs
- Delivery Devices
- South East Asia Human Insulin Market, by Product Type
- Insulin Analoys & Biosimilars
- Human Insulin Biologics
- South East Asia Human Insulin Market, by Diabetes Type
- Diabetes 1
- Diabetes 2
- South East Asia Human Insulin Market, by Delivery Devices
- Pens
- Pen Needles
- Syringes
- South East Asia Human Insulin Market, by Product
-
Rest of Asia Pacific
- Rest of Asia Pacific Human Insulin Market, by Product
- Drugs
- Delivery Devices
- Rest of Asia Pacific Human Insulin Market, by Product Type
- Insulin Analoys & Biosimilars
- Human Insulin Biologics
- Rest of Asia Pacific Human Insulin Market, by Diabetes Type
- Diabetes 1
- Diabetes 2
- Rest of Asia Pacific Human Insulin Market, by Delivery Devices
- Pens
- Pen Needles
- Syringes
- Rest of Asia Pacific Human Insulin Market, by Product
-
Asia Pacific Human Insulin Market, by Product
- Latin America
-
Latin America Human Insulin Market, by Product
- Drugs
- Delivery Devices
-
Latin America Human Insulin Market, by Product Type
- Insulin Analoys & Biosimilars
- Human Insulin Biologics
-
Latin America Human Insulin Market, by Diabetes Type
- Diabetes 1
- Diabetes 2
-
Latin America Human Insulin Market, by Delivery Devices
- Pens
- Pen Needles
- Syringes
- Brazil
- Brazil Human Insulin Market, by Product
- Drugs
- Delivery Devices
- Brazil Human Insulin Market, by Product Type
- Insulin Analoys & Biosimilars
- Human Insulin Biologics
- Brazil Human Insulin Market, by Diabetes Type
- Diabetes 1
- Diabetes 2
- Brazil Human Insulin Market, by Delivery Devices
- Pens
- Pen Needles
- Syringes
- Brazil Human Insulin Market, by Product
- Argentina
- Argentina Human Insulin Market, by Product
- Drugs
- Delivery Devices
- Argentina Human Insulin Market, by Product Type
- Insulin Analoys & Biosimilars
- Human Insulin Biologics
- Argentina Human Insulin Market, by Diabetes Type
- Diabetes 1
- Diabetes 2
- Argentina Human Insulin Market, by Delivery Devices
- Pens
- Pen Needles
- Syringes
- Argentina Human Insulin Market, by Product
-
Rest of Latin America
- Rest of Latin America Human Insulin Market, by Product
- Drugs
- Delivery Devices
- Rest of Latin America Human Insulin Market, by Product Type
- Insulin Analoys & Biosimilars
- Human Insulin Biologics
- Rest of Latin America Human Insulin Market, by Diabetes Type
- Diabetes 1
- Diabetes 2
- Rest of Latin America Human Insulin Market, by Delivery Devices
- Pens
- Pen Needles
- Syringes
- Rest of Latin America Human Insulin Market, by Product
-
Latin America Human Insulin Market, by Product
- Middle East & Africa
-
Middle East & Africa Human Insulin Market, by Product
- Drugs
- Delivery Devices
-
Middle East & Africa Human Insulin Market, by Product Type
- Insulin Analoys & Biosimilars
- Human Insulin Biologics
-
Middle East & Africa Human Insulin Market, by Diabetes Type
- Diabetes 1
- Diabetes 2
-
Middle East & Africa Human Insulin Market, by Delivery Devices
- Pens
- Pen Needles
- Syringes
- GCC Countries
- GCC Countries Human Insulin Market, by Product
- Drugs
- Delivery Devices
- GCC Countries Human Insulin Market, by Product Type
- Insulin Analoys & Biosimilars
- Human Insulin Biologics
- GCC Countries Human Insulin Market, by Diabetes Type
- Diabetes 1
- Diabetes 2
- GCC Countries Human Insulin Market, by Delivery Devices
- Pens
- Pen Needles
- Syringes
- GCC Countries Human Insulin Market, by Product
- South Africa
- South Africa Human Insulin Market, by Product
- Drugs
- Delivery Devices
- South Africa Human Insulin Market, by Product Type
- Insulin Analoys & Biosimilars
- Human Insulin Biologics
- South Africa Human Insulin Market, by Diabetes Type
- Diabetes 1
- Diabetes 2
- South Africa Human Insulin Market, by Delivery Devices
- Pens
- Pen Needles
- Syringes
- South Africa Human Insulin Market, by Product
-
Rest of Middle East & Africa
- Rest of Middle East & Africa Human Insulin Market, by Product
- Drugs
- Delivery Devices
- Rest of Middle East & Africa Human Insulin Market, by Product Type
- Insulin Analoys & Biosimilars
- Human Insulin Biologics
- Rest of Middle East & Africa Human Insulin Market, by Diabetes Type
- Diabetes 1
- Diabetes 2
- Rest of Middle East & Africa Human Insulin Market, by Delivery Devices
- Pens
- Pen Needles
- Syringes
- Rest of Middle East & Africa Human Insulin Market, by Product
-
Middle East & Africa Human Insulin Market, by Product
- North America
Vantage Market
Research | 01-Dec-2022
FAQ
Frequently Asked Question
What is the global demand for Human Insulin in terms of revenue?
-
The global Human Insulin valued at USD 22.66 Billion in 2022 and is expected to reach USD 28.71 Billion in 2030 growing at a CAGR of 3.00%.
Which are the prominent players in the market?
-
The prominent players in the market are Novo Nordisk A/S (Denmark), Eli Lilly & Company (US), Boston Scientific Corporation (US), Sanofi (France), Boehringer Ingelheim International GmbH (Germany), Biocon (India), Tonghua Dongbao Pharmaceutical (China), Julphar (UAE), Wockhardt (India).
At what CAGR is the market projected to grow within the forecast period?
-
The market is project to grow at a CAGR of 3.00% between 2023 and 2030.
What are the driving factors fueling the growth of the market.
-
The driving factors of the Human Insulin include
- Increase in prevalence of diabetes
Which region accounted for the largest share in the market?
-
North America was the leading regional segment of the Human Insulin in 2022.
